# Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells

> **Open Intelligence Dossier** · First detected: 2026-06-26 22:07 UTC · Category: Business

## Executive Summary
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells" is generating significant coverage in the Business category, with 2 articles from 2 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Yahoo Finance and Clinical Trials Arena. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | Moderna Is Up 14% Today: Is It Outperforming Other Vaccine Stocks Like Merck and Pfizer? | [Source Link](https://news.google.com/rss/articles/CBMiowFBVV95cUxPQXRaMHdNQkdmS3dYNkdqUS1YZGZNVkxJSXlCWVUyMWV5MThWMWFRZVlwQWliazdxQ2lxcnc2Z1Bhc2xGdXFYVTJwQjdUZVdVaWRqdU0zMnEybzBNX0FBWHNlWUtlY2ttSV9HNjNpcVYzS1pnZmFhQ093S29tVzc2eEVSenk3YWZRdVYtLUtYRGdtNjJvVFd2cGEtZ2RFWVhmemxr?oc=5) |
| Clinical Trials Arena | Moderna highlights expanding mRNA platform at Science Day | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxOaUxReGMzZGJDMGRMLTJWeXFiNk9tNDE5VUpFNEQ4UUhZUUJqTGtGNFlyZS11emJKOW5hQ3VaN3MtbGFOQ2pFWVVhWkd4UjJZaEN5UXJ3T056d29Yal9xZ3RoTUJEc2sxZElrbGFBSFp0U0FBR1NGWUtBbTFXWHdwdnpOMmlKclRudnliS2g0d0JBOXVVS1JPYXlfV2Q2LXVz?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-26/moderna-enters-in-vivo-car-t-granting-autoimmune-asset-007-license-to-kill*